A drug with the SMILES Cc1ccc(C)c(Cn2nnc3c(=O)[nH]c(C4CCN(S(=O)(=O)c5ccc(S(=O)(=O)N(C)C)cc5)CC4)nc32)c1 has a human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM of 22.753\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Cc1ccc(C)c(Cn2nnc3c(=O)[nH]c(C4CCN(S(=O)(=O)c5ccc(S(=O)(=O)N(C)C)cc5)CC4)nc32)c1
Cc1ccc(C)c(Cn2nnc3c(=O)[nH]c(C4CCN(S(=O)(=O)c5ccc(S(=O)(=O)N(C)C)cc5)CC4)nc32)c1
4-[4-[3-[(2,5-dimethylphenyl)methyl]-7-oxo-6H-triazolo[4,5-d]pyrimidin-5-yl]piperidin-1-yl]sulfonyl-N,N-dimethylbenzenesulfonamide